Developing a vaccine to protect against SARS-CoV-2 using advanced technology.
To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology
['FUNDING_OTHER'] · COLORADO STATE UNIVERSITY · NIH-11059026
This study is working on a new vaccine to help protect people from COVID-19 by using a special technology to make it safe, and it’s designed for anyone who wants better protection against the virus and similar illnesses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLORADO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (FORT COLLINS, UNITED STATES) |
| Trial ID | NIH-11059026 on ClinicalTrials.gov |
What this research studies
This research focuses on creating an inactivated vaccine for SARS-CoV-2, the virus responsible for COVID-19, using blood pathogen reduction technology. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and performing immunogenicity and efficacy evaluations in animal models. The research aims to ensure the vaccine is safe and effective before it is submitted for clinical trials. Patients may benefit from a new vaccine that could provide protection against COVID-19 and similar infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of contracting COVID-19 or those who may benefit from vaccination against emerging infectious diseases.
Not a fit: Patients who are already vaccinated against COVID-19 or those with contraindications to vaccination may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a safe and effective vaccine that protects patients from COVID-19 and other emerging infectious diseases.
How similar studies have performed: Other research has shown success in developing vaccines using similar technologies, indicating a promising approach for this project.
Where this research is happening
FORT COLLINS, UNITED STATES
- COLORADO STATE UNIVERSITY — FORT COLLINS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOODRICH, RAYMOND — COLORADO STATE UNIVERSITY
- Study coordinator: GOODRICH, RAYMOND
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Communicable Diseases, Disease Outbreaks